This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (705K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
AVIGAN J, STEINBERG D, VROMAN HE, THOMPSON MJ, MOSETTIG E. Studies of cholesterol biosynthesis. I. The identification of desmosterol in serum and tissues of animals and man treated with MER-29. J Biol Chem. 1960 Nov;235:3123–3126.[PubMed]
BLOHM TR, KARIYA T, MACKENZIE RD. Excretory products of the sterol biosynthetic pathway in the MER-29-treated rat. Excretion of MER-29. Prog Cardiovasc Dis. 1960 May;2:519–523.[PubMed]
CORCORAN AC. Coronary atherosclerosis status of MER-29 (triparanol). Am Heart J. 1961 Apr;61:431–435.[PubMed]
ESTES JE. Clinical experience with MER-29, an inhibitor of cholesterol synthesis. Prog Cardiovasc Dis. 1960 May;2:564–570.[PubMed]
FRANTZ ID, Jr, MOBBERLEY ML, SCHROEPFER GJ., Jr Effects of MER-29 on the intermediary metabolism of cholesterol. Prog Cardiovasc Dis. 1960 May;2:511–518.[PubMed]
HALPERIN MH. A clinical study of MER-29 in patients with angina pectoris. Prog Cardiovasc Dis. 1960 May;2:631–636.[PubMed]
HOLLANDER W, CHOBANIAN AV, WILKINS RW. The effects of triparanol (MER-29) in subjects with and without coronary artery disease. JAMA. 1960 Sep 3;174:5–12.[PubMed]
JOSE AD, LEAROYD B, PEAK H. The treatment of hypercholesterolaemia by MER-29. Med J Aust. 1961 Dec 9;48(2):938–943.[PubMed]
KOUNTZ WB. Clinical observations on the effects of MER-29. Prog Cardiovasc Dis. 1960 May;2:541–543.[PubMed]
LECKERT JT, MCHARDY GG, MCHARDY RJ, WELCH GE, CRADIC H. Clinical evaluation of MER-29 in the treatment of hypercholesterolemia associated with atherosclerosis. Prog Cardiovasc Dis. 1960 May;2:571–575.[PubMed]
LISAN P. Prognostic significance of triparanol (MER-29). Prog Cardiovasc Dis. 1960 May;2:618–621.[PubMed]
OAKS W, LISAN P, MOYER JM. Inhibition of cholesterol synthesis with the use of Mer-29. Arch Intern Med. 1959 Oct;104:527–531.[PubMed]